Is ruxolitinib a potentially useful drug in hematological malignancies with RAS pathway hyperactivation?
Haematologica
; 101(12): e492, 2016 12.
Article
in En
| MEDLINE
| ID: mdl-27903714
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematologic Neoplasms
/
Myeloproliferative Disorders
/
Neoplasms
Limits:
Humans
Language:
En
Journal:
Haematologica
Year:
2016
Document type:
Article
Affiliation country:
Austria